156 related articles for article (PubMed ID: 35867730)
1. Hypnozoite depletion in successive Plasmodium vivax relapses.
Noviyanti R; Carey-Ewend K; Trianty L; Parobek C; Puspitasari AM; Balasubramanian S; Park Z; Hathaway N; Utami RAS; Soebianto S; Jeny J; Yudhaputri F; Perkasa A; Coutrier FN; Tirta YK; Ekawati L; Tjahyono B; Sutanto I; Nelwan EJ; Sudoyo H; Baird JK; Lin JT
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010648. PubMed ID: 35867730
[TBL] [Abstract][Full Text] [Related]
2. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals.
Chen N; Auliff A; Rieckmann K; Gatton M; Cheng Q
J Infect Dis; 2007 Apr; 195(7):934-41. PubMed ID: 17330782
[TBL] [Abstract][Full Text] [Related]
3. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
4. Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection.
de Araujo FC; de Rezende AM; Fontes CJ; Carvalho LH; Alves de Brito CF
PLoS One; 2012; 7(11):e49871. PubMed ID: 23185469
[TBL] [Abstract][Full Text] [Related]
5. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
[TBL] [Abstract][Full Text] [Related]
6. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
Imwong M; Snounou G; Pukrittayakamee S; Tanomsing N; Kim JR; Nandy A; Guthmann JP; Nosten F; Carlton J; Looareesuwan S; Nair S; Sudimack D; Day NP; Anderson TJ; White NJ
J Infect Dis; 2007 Apr; 195(7):927-33. PubMed ID: 17330781
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analyses Reveal the Common Occurrence and Complexity of
Popovici J; Friedrich LR; Kim S; Bin S; Run V; Lek D; Cannon MV; Menard D; Serre D
mBio; 2018 Jan; 9(1):. PubMed ID: 29362233
[No Abstract] [Full Text] [Related]
8. Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.
Lin JT; Hathaway NJ; Saunders DL; Lon C; Balasubramanian S; Kharabora O; Gosi P; Sriwichai S; Kartchner L; Chuor CM; Satharath P; Lanteri C; Bailey JA; Juliano JJ
J Infect Dis; 2015 Sep; 212(6):999-1008. PubMed ID: 25748326
[TBL] [Abstract][Full Text] [Related]
9. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar.
Andrianaranjaka V; Lin JT; Golden C; Juliano JJ; Randrianarivelojosia M
Malar J; 2013 May; 12():177. PubMed ID: 23721298
[TBL] [Abstract][Full Text] [Related]
10.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
11. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium vivax Relapse Rates in Allied Soldiers during the Second World War: Importance of Hypnozoite Burden.
Shanks GD
Am J Trop Med Hyg; 2022 Dec; 107(6):1173-1177. PubMed ID: 36343595
[TBL] [Abstract][Full Text] [Related]
13. Biological concepts in recurrent Plasmodium vivax malaria.
Markus MB
Parasitology; 2018 Nov; 145(13):1765-1771. PubMed ID: 29564998
[TBL] [Abstract][Full Text] [Related]
14. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
Maneerattanasak S; Gosi P; Krudsood S; Chimma P; Tongshoob J; Mahakunkijcharoen Y; Sukasem C; Imwong M; Snounou G; Khusmith S
Malar J; 2017 May; 16(1):228. PubMed ID: 28558712
[TBL] [Abstract][Full Text] [Related]
15. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
[TBL] [Abstract][Full Text] [Related]
17. An Activation-Clearance Model for Plasmodium vivax Malaria.
Mehra S; McCaw JM; Flegg MB; Taylor PG; Flegg JA
Bull Math Biol; 2020 Feb; 82(2):32. PubMed ID: 32052192
[TBL] [Abstract][Full Text] [Related]
18. Do hypnozoites cause relapse in malaria?
Markus MB
Trends Parasitol; 2015 Jun; 31(6):239-45. PubMed ID: 25816801
[TBL] [Abstract][Full Text] [Related]
19. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
[TBL] [Abstract][Full Text] [Related]
20. Population heterogeneity in Plasmodium vivax relapse risk.
Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010990. PubMed ID: 36534705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
